99 Avsnitt

  1. CSF proteomics in glioma

    Publicerades: 2025-03-21

  2. Vorasidenib in IDH mutant glioma

    Publicerades: 2025-03-08

  3. KL-50 in post TMZ MMR-deficient GBM

    Publicerades: 2025-02-22

  4. Measurable disease per FET-PET vs MRI in GBM

    Publicerades: 2025-02-08

  5. Pre-radiation chemotherapy in GBM

    Publicerades: 2025-01-20

  6. cIMPACT-NOW Update 8: grading of meningiomas

    Publicerades: 2024-12-13

  7. Residual tumor volume and survival after CCNU/TMZ in GBM

    Publicerades: 2024-11-24

  8. Alterations in RNA splicing between meningioma DNA methylation groups

    Publicerades: 2024-11-08

  9. The immune landscape of IDH mutant and IDHwt glioma

    Publicerades: 2024-10-25

  10. Equity-driven applications of AI in neuro-oncology

    Publicerades: 2024-10-09

  11. IDH mutant glioma across age groups

    Publicerades: 2024-09-20

  12. Contemporary molecular prognostic signatures in glioma

    Publicerades: 2024-08-30

  13. FDG PET in PCNSL

    Publicerades: 2024-08-09

  14. TMZ and MGMT in elderly GBM patients

    Publicerades: 2024-07-12

  15. IDH mutant glioma and IDH inhibitors

    Publicerades: 2024-07-05

  16. Leptomeningeal disease, a SNO and ASCO review

    Publicerades: 2024-06-28

  17. Cancer stems cell in GBM

    Publicerades: 2024-06-21

  18. Drug delivery across the blood-brain barrier

    Publicerades: 2024-06-13

  19. Gliomatosis cerebri in children

    Publicerades: 2024-05-24

  20. Immunotherapy drives mesenchymal shift in GBM

    Publicerades: 2024-05-17

1 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site